Use of aspirin for primary and secondary prevention of cardiovascular disease in diabetic patients in an ambulatory care setting in Spain
<p>Abstract</p> <p>Background</p> <p>This study was conducted in order to determine the use of aspirin and to assess the achievement of therapeutic targets in diabetic patients according to primary (PP) or secondary prevention (SP).</p> <p>Methods</p>...
Main Authors: | Fernández-de-Bobadilla Jaime, Rejas-Gutiérrez Javier, Navarro-Artieda Ruth, Sicras-Mainar Antoni, Frías-Garrido Xavier, Ruiz-Riera Rafael |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2007-10-01
|
Series: | BMC Family Practice |
Online Access: | http://www.biomedcentral.com/1471-2296/8/60 |
Similar Items
-
Comparative effectiveness and costs of generic and brand-name gabapentin and venlafaxine in patients with neuropathic pain or generalized anxiety disorder in Spain
by: Sicras-Mainar A, et al.
Published: (2015-06-01) -
Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain
by: Javier Rejas-Gutierrez, et al.
Published: (2021-04-01) -
Impact on healthcare resource utilization of multiple sclerosis in Spain
by: Antoni Sicras-Mainar, et al.
Published: (2017-12-01) -
Combinación de metformina frente a inhibidores de la dipeptidilpeptidasa y sulfonilureas en el tratamiento de la diabetes tipo 2: impacto clínico y económico
by: Antoni Sicras-Mainar, et al. -
Combinación de metformina frente a inhibidores de la dipeptidilpeptidasa y sulfonilureas en el tratamiento de la diabetes tipo 2: impacto clínico y económico
by: Antoni Sicras-Mainar, et al.